LifeMD, Inc. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Pediatrix Medical Group, Inc.

Enhabit, Inc.

The Pennant Group, Inc.

Talkspace, Inc.

DocGo, Inc.

Hims & Hers Health, Inc.

OPKO Health, Inc.

CareMax, Inc.

Fulgent Genetics, Inc.

LifeMD, Inc.

Celldex Therapeutics, Inc.

Why is LifeMD, Inc. ?

With a fall in Net Sales of -5.75%, the company declared Very Negative results in Jun 26

The company has declared negative results for the last 2 consecutive quarters
PRE-TAX PROFIT(Q) At USD -7.08 MM has Fallen at -106.11%
NET PROFIT(Q) At USD -7.08 MM has Fallen at -92.95%
OPERATING CASH FLOW(Y) Lowest at USD -9.92 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -46.14%, its profits have risen by 83.2%

Below par performance in long term as well as near term

Along with generating -46.14% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is LifeMD, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

LifeMD, Inc.

-46.14%

-0.66

79.87%

S&P 500

22.36%

1.70

13.18%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

44.50%

EBIT Growth (5y)

14.58%

EBIT to Interest (avg)

-23.04

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

6.65

Sales to Capital Employed (avg)

24.89

Tax Ratio

4.12%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

56.83%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

7.72

EV to EBIT

-99.74

EV to EBITDA

15.87

EV to Capital Employed

-10.99

EV to Sales

0.61

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-13.57%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

Bearish

No Signal

Bollinger Bands

Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Mildly Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -4.59% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -240.06 %

-27What is not working for the Company

PRE-TAX PROFIT(Q)

At USD -7.08 MM has Fallen at -106.11%

NET PROFIT(Q)

At USD -7.08 MM has Fallen at -92.95%

OPERATING CASH FLOW(Y)

Lowest at USD -9.92 MM

ROCE(HY)

Lowest at -674.34%

NET SALES(Q)

At USD 47.28 MM has Fallen at -13.81%

DEBTORS TURNOVER RATIO(HY)

Lowest at 22 times

Here's what is working for LifeMD, Inc.

Debt-Equity Ratio

Lowest at -240.06 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by -4.59% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for LifeMD, Inc.

Pre-Tax Profit

At USD -7.08 MM has Fallen at -106.11%

over average net sales of the previous four periods of USD -3.44 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit

At USD -7.08 MM has Fallen at -92.95%

over average net sales of the previous four periods of USD -3.67 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Net Sales

At USD 47.28 MM has Fallen at -13.81%

over average net sales of the previous four periods of USD 54.86 MM

MOJO Watch

Near term sales trend is very negative

Net Sales (USD MM)

Operating Cash Flow

Lowest at USD -9.92 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Debtors Turnover Ratio

Lowest at 22 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio